ArticleRadiology case reports2025
Aggressive high-grade urothelial carcinoma transforming into enteric-type adenocarcinoma: a case report.
Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bladder cancer, a malignancy with high morbidity and mortality, predominantly affects older adults, with urothelial carcinoma as the most common histological type. However, enteric-type adenocarcinoma arising from high-grade urothelial carcinoma is an exceptionally rare and aggressive variant. This report details the case of a 44-year-old woman diagnosed at Rural Hospital. She presented with hematuria and frequent micturition, leading to a diagnosis of high-grade urothelial carcinoma with villoglandular differentiation. Despite multiple chemotherapy cycles (Gemcitabine-Carboplatin, followed by MVAC), the tumor progressed. Imaging revealed extensive invasion, necessitating radical anterior exenteration, including cystectomy, hysterectomy, and ileal conduit construction. Histopathology confirmed transformation into enteric-type adenocarcinoma with perineural and lymphovascular invasion but no lymph node metastases. Adjuvant radiotherapy was administered to mitigate recurrence risk. This case underscores the complexities of managing aggressive bladder carcinoma with histological transformation and highlights the need for a multimodal treatment strategy. Individualized approaches integrating surgery, chemotherapy, and radiotherapy are crucial. Further research is needed to establish standardized protocols and identify biomarkers for early detection and targeted therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.